Empagliflozin's Ameliorating Effect on Plasma Triglycerides: Association with Endothelial Function Recovery in Diabetic Patients with Coronary Artery Disease

Aim: So far, the mechanisms behind the cardiovascular benefits of sodium/glucose cotransporter 2 (SGLT2) inhibitors have not been fully clarified. Methods: In order to evaluate the effects of SGLT2 inhibitors on systemic hemodynamics, glucose metabolism, lipid profile, and endothelial function, 50 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawada, Takahiro, Uzu, Kenzo, Hashimoto, Naoko, Onishi, Tetsuari, Takaya, Tomofumi, Shimane, Akira, Taniguchi, Yasuyo, Yasaka, Yoshinori, Ohara, Takeshi, Kawai, Hiroya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406405/
https://www.ncbi.nlm.nih.gov/pubmed/31631099
http://dx.doi.org/10.5551/jat.50807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406405/
https://www.ncbi.nlm.nih.gov/pubmed/31631099
http://dx.doi.org/10.5551/jat.50807

Ejemplares similares